ArticleBMC nutrition2025
Anemia status and associated factors among adolescent girls under weekly iron and folic acid supplementation (WIFAS) and non-WIFAS programs in public schools in Janamora district, Northwest Ethiopia 2023; a comparative cross-sectional study.
Article in BMC nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnemia is the most common nutritional problem in impoverished countries, particularly among adolescents. Adolescents have a unique opportunity to enhance their nutritional status. Weekly iron‒folic acid supplementation can halt the intergenerational cycle of anemia. Numerous studies have revealed a statistically significant link between taking iron folic acid supplements and preventing anemia. Therefore, this study aimed to compare the differences in the prevalence of anemia and associated factors among adolescent girls in public schools that implemented weekly iron folic acid supplementation (WIFAS) and those that did not in Janamora district, Northwest Ethiopia, in 2023.
methodsA school-based comparative cross-sectional study was conducted among (361) adolescent girls on (180) WIFAS and (181) non-WIFAS schools Programme. We selected the participants via simple random multistage sampling techniques. Data were collected using an interviewer-based questionnaire, anthropometric measurements, and a hemoglobin level test. Hemoglobin estimation was performed by using the HemoCue Hb 301 machine. Descriptive and multivariate logistic regression analyses was performed via STATA Version 17 to identify a significant association between anemia and its associated variables at a p-value < 0.05.
resultsThe overall prevalence of anemia was 50.43% (CI: 45%, 55%). However, its prevalence was 44.7% (CI: 37.4%, 52.3%) among the WIFAS schools and 56% (CI: 48.5%, 63.3%) among the non-WIFAS schools, with statistically significant differences at p < 0.05. The habit of drinking coffee/teas [AOR = 5.9] and secondary school girls [AOR = 2.5] among non-WIFAS school programs, whereas poor adherence to the IFAs [AOR = 3.6], poor anemia knowledge [AOR = 4.4], and non-vegetarian status [AOR = 2.8] among WIFAS school programs. Furthermore, parasite attack history [AOR = 6.9, and 7.6] for each program was a statistically significant factor among adolescent girls.
conclusionAnemia was less prevalent in the WIFAS school Programme than in the non-WIFAS school Programme. This indicates that the WIFAS has an important function in improving anemic status. As a result, it is recommended that the WIFAS program be extended to more schools. The WIFAS program is more effective when health education is delivered concurrently with it.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.